The European cancer screening guidelines recommend colorectal cancer (CRC) screening for 50-74-year-olds. CRC mortality can be reduced with screening, but it is yet unclear if CRC screening affects various lifestyle related factors. Due to population-level nature of screening, even minor adverse effects in health related lifestyle might have relevance for public health. A national programme for CRC screening with repeated faecal occult blood (FOB) testing followed by colonoscopy for test positives has been running in Finland since 2004. Our aim is to clarify, if screening is introducing harmful effects on colorectal cancer risk related life style, thus reducing the potential benefit of an otherwise feasible screening programme. Methods A population-based random sample of 10648 Finnish adults born in 1951 living in the municipalities voluntary involved in CRC screening programme were sent a lifestyle questionnaire in 2010. In 2011, the 60-year old cohort was independently randomised (1:1) for their first ever CRC screening (invited) or control group (not contacted). The questionnaires were repeated in 2012 for all. From both survey rounds, 2508 pairs of completed questionnaires were available for analysis from the screening group and 2387 from the control group. The outcome was 2-year change in total lifestyle score of CRC risk related lifestyle factors (smoking, alcohol consumption, physical activity, diet and BMI).
Background
The European cancer screening guidelines recommend colorectal cancer (CRC) screening for 50-74-year-olds. CRC mortality can be reduced with screening, but it is yet unclear if CRC screening affects various lifestyle related factors. Due to population-level nature of screening, even minor adverse effects in health related lifestyle might have relevance for public health. A national programme for CRC screening with repeated faecal occult blood (FOB) testing followed by colonoscopy for test positives has been running in Finland since 2004. Our aim is to clarify, if screening is introducing harmful effects on colorectal cancer risk related life style, thus reducing the potential benefit of an otherwise feasible screening programme. Methods A population-based random sample of 10648 Finnish adults born in 1951 living in the municipalities voluntary involved in CRC screening programme were sent a lifestyle questionnaire in 2010. In 2011, the 60-year old cohort was independently randomised (1:1) for their first ever CRC screening (invited) or control group (not contacted). The questionnaires were repeated in 2012 for all. From both survey rounds, 2508 pairs of completed questionnaires were available for analysis from the screening group and 2387 from the control group. The outcome was 2-year change in total lifestyle score of CRC risk related lifestyle factors (smoking, alcohol consumption, physical activity, diet and BMI).
Results
Preliminary results indicate that total lifestyle scores improved likewise in the screening group and in controls suggesting favourable changes for CRC risk in both groups. There was no difference by participation, either: the change in score did not differ in those participating screening compared to those invited, but not participated screening. Conclusions Present study found no unfavourable changes in total lifestyle in the studied age group after CRC screening. However, life style counselling could be included in screening setting.
Key messages:
Invitation or participation to colorectal cancer screening was not found to have a adverse effect on colorectal cancer risk related lifestyle in a population-based survey study in Finland Potential lifestyle change after colorectal cancer screening should be evaluated programme-wise. In Finland, this does not affect the cost-benefit ratio of the colorectal cancer screening programme 
Background
General practitioners (GPs) use gut feelings to diagnose cancer in an early stage, but little is known about the predictive value of gut feelings and how this is influenced by patient and GP characteristics. Methods Prospective cohort study of patients in 44 general practices throughout the Netherlands, from January 2010 till December 2013. GPs completed a questionnaire regarding gut feelings, patient and GP characteristics, if they noticed a cancer-related gut feeling during patient consultation. Follow-up questionnaires were sent 3 months later requesting information about the patient's diagnosis. Chi-square, uni-and multivariate logistic regression and multilevel analyses were performed. Results A gut feeling (N = 366) is most often triggered by weight loss (24%, N = 85) and rare GP visits (22%, N = 76), but none of the triggers were predictive of cancer in a multivariate analysis except for patient's (P = 0.01) and doctor's age (P = 0.04). Most GPs (95%) acted immediately on the gut feeling, either referring to a specialist or by performing additional medical tests. The average positive predictive value of cancer related gut feeling was 35%. This increases with 2% for every year a patient becomes older, and with 3% for every year a GP becomes older. Conclusions GP's gut feeling for cancer proves to be a useful tool in diagnosing cancer and its relative high predicting value increases if the GP is older or more experienced and when the patient is older. The value of GP's gut feeling needs more attention in guidelines and medical training concerning cancer. 
This study represents an attempt to synthesize the current knowledge on the relationship between genetic polymorphisms, occupational exposures and urinary tract cancers. Methods We carried out a literature search in MEDLINE, ISI Web of science, and SCOPUS online databases of all articles published in English language up to February 2015. Meta-analysis was performed in order to provide summary estimates for the association between a certain genetic polymorphisms, occupational exposures and bladder (BC) or kidney cancer (KC), when appropriate. Results Thirteen studies on BC and six on KC were deemed eligible for the review. Concerning BC, an overall OR of 2.07 (95 % CI, 1.38-3.09) for those with GSTM1 and an OR of 2.07 (95% CI, 1.38-3.09) for those with GSTT1 Null Genotypes carriers was reported when exposed to polycyclic aromatic hydrocarbons (PAHs). NAT2 slow genotype carriers had an OR of 3.59 (95% CI, 2.62-4.93) for BC when exposed to aromatic amines (AAs) and an OR of 2.07 (95% CI, 1.36-3.15) when exposed to PAHs. Concerning KC and pesticide exposure, the meta-analysis reported an OR of 4.38 (95% CI, 2.28-8.41) for GSTM1 present genotype, an OR of 2.59 (95% CI, 1.62-4.15) for GSTT1 present genotype and an OR 6.51 (95% CI, 2.85-14.89) for combined effects of GSTM1 and GSTT1 active genotypes. Conclusions This meta-analysis indicates a possible association between the variant genotypes of GSTM1, GSTT1, NAT2 and SULT1A1, occupational exposures to AAs or PAHs and development of BC. Our results suggest that polymorphisms in GSTM1 and GSTT1 genes could influence risk for developing KC in individuals occupationally exposed to pesticides.
Key messages:
development of BC is possibly associated to the variant genotypes of GSTM1, GSTT1, NAT2 and SULT1A1, occupational exposures to AAs or PAHs polymorphisms in GSTM1 and GSTT1 genes could influence risk for developing KC in individuals occupationally exposed to pesticides Association between Mediterranean diet and gastric cancer: Results of a case-control study in Italy Background High Mediterranean diet adherence is associated with reduced risk of overall cancer mortality as well as a reduced risk of incidence of several cancer types, especially cancers of the colorectum, breast, and head and neck. However, only a few studies investigated the association between gastric cancer risk and adherence to the Mediterranean diet. Methods A case-control study was conducted at the Gemelli Hospital of Rome, Italy. A total of 226 cases and 444 controls were interviewed. Dietary intake was assessed through a validated food frequency questionnaire that collected information on over 25 food items. A Mediterranean diet score was used to evaluate the level of adherence to the traditional Mediterranean dietary pattern. Odds Ratios (ORs) and 95% confidence intervals (CI) were estimated for increasing levels of the score using multiple logistic regression models. Background Although Prostate-Specific antigen (PSA) screening is currently the most used prostate cancer (PCa) screening method, its benefits are still controversial. In absence of empirical data on the lifetime consequences of screening and potential overdiagnosis, which is difficult to assess in empirical studies, mathematical models are frequently used to assess the benefit-harm balance of PSA screening. Such models differ in methodological features and provide controversial results. The goal of our study is to conduct a systematic review which will answer (1) What are the necessary features that should be included in models evaluating the benefit and harms of PCa screening? and (2) How can those affect the model-generated benefit-harm results? Methods We performed a systematic literature search for studies modeling the effect of PSA screening in PUBMED up to March 2016. For extracting methodological features, we applied a set of criteria based on identifying key variables or processes that a PCa screening model should have to provide a comprehensive and unbiased benefit-harm evaluation. Results We identified 41 articles based on 28 models. 24 of those used a stage-shift approach to model the screening effects. Healthrelated quality of life (HRQOL) was considered in nine models. Six of the models explicitly modeled the preclinical phase and only ten models controlled for overdiagnosis. Nine models validated the clinical incidence, stage distribution at clinical diagnosis and survival against published data. Conclusions PCa screening models differ in important methodological aspects. Understanding the consequences of using some features will enable easier interpretation of the results and improvement in future modeling. Results Each year about 7 000 rare cancers were diagnosed, which is 18% of all newly diagnosed cancer cases per year. 84% of all second-layer entities (183) were rare, 13 entities were not observed, and 2 entities (epithelial skin tumours) were not collected. Rare haematological, digestive, and head and neck cancers were most common comprising 57% of all rare cancers. Five-year relative survival remained stable in 2000-2009 at 53% for all rare cancers, varying from 22% (digestive cancers) to 93% (male genital cancers). 60 000 patients with a rare cancer were alive at the end of 2012 (19% of total cancer prevalence). Conclusions In Austria, almost one in six cancer cases among adults is a rare cancer. This is in line with the European results. Taking into account that this group consists of at least 183 different entities indicates the challenge that health care faces. Therefore increased awareness among clinicians and policy makers is needed, leading to improvement of diagnostics and treatment by (inter)national cooperation and concentration of care. Preferably, the next national cancer plan should focus on rare cancer.
18% of all newly diagnosed cancer cases per year are rare cancers among adults in Austria 183 different rare cancer entities indicate a big challenge for clinicians and policy makers 
Background
The benefit-harm balance of prostate cancer (PCa) screening is influenced by individual risk factors, preferences, and specifics of the applied screening algorithm. We used the ONCOTYROL Prostate Cancer Outcome and Policy (PCOP) model to identify optimal screening strategies with respect to individual family history, age, disutility weighting, and lifeshortening co-morbidity. Methods The PCOP model is a state-transition micro-simulation model simulating the consequences of PCa screening and treatment on duration and quality of life. Evaluated strategies included no screening, one-time screening at different ages, and interval screening at different intervals and age ranges followed by immediate treatment. Sensitivity analyses were used to identify strategies maximizing quality-adjusted life expectancy (QALE) for each combination of individual risk factors and disutility weighting. Screening was also evaluated in combination with biennial active surveillance (AS) delaying treatment of localized cancer until progression to Gleason score ! 7. Results In men without elevated familial PCa risk, no screening was the preferred strategy, independent of age, disutility weighting and life-shortening co-morbidity. In contrast, men with elevated familial risk gained QALE depending on their risk and preference constellation. Optimal screening strategies varied as well. AS improved the benefit-harm balance of some screening strategies. However, strategies gaining the most QALE in men with familial risk gained less when combined with AS. Conclusions Based on our model assumptions, PCa screening is beneficial for men with familial predisposition only. However, benefits of screening depend on individual risks and preferences. AS may reduce benefits of screening, when gains by averted overtreatment are outweighed by losses due to delayed treatment. Background Recent data show that more than one quarter of adult inhabitants of Croatia are everyday smokers. The aim of this study was to determine trends of trachea and lung cancer incidence in Croatia, Zagreb and Split-Dalmatia County (SDC) and compare them between regions, to stress importance of comprehensive tobacco control program. Methods Incidence data for the period 2001 -2013 were obtained from the Croatian National Cancer Registry and European Health for All Database. For calculating incidence rates per 100.000 9th European Public Health Conference: Poster Walks persons we used Censuses from years 2001 and 2011. Agestandardized rates of lung cancer incidence were calculated by the direct standardization method using the European Standard Population. To describe incidence trends we used joinpont regression analysis. Results Lung cancer incidence rates in men show declining trend. Joinpoint analysis showed a significant decrease in the incidence for all regions, with estimated annual percentage change (EAPC) for Zagreb of -4.3%, for Croatia of -2.3%, and for SDC of -1.6%. In women there is an increasing trend. Joinpoint analysis showed a significant increase in the incidence for Croatia with EAPC of 1.6%. There was no significant increase for Zagreb and SDC. In terms of both sexes, joinpoint analysis showed a significant decrease in agestandardized incidence rates for Croatia with EAPC of -1%. There were no significant results for SDC and Zagreb.
Conclusions
This study shows there is an increase in female lung cancer incidence rate and a decrease in male lung cancer incidence rate. Those findings correlate with decreasing trend of smoking prevalence among men and increasing trend among women. Despite all of that, Croatia is still among the European countries with the highest lung cancer incidence. These Results stress importance of smoking prevention and cessation policies especially among women and young people.
Key messages:
Croatia is among the EU countries with the highest lung cancer incidence That raises question about introducing screening in highrisk population and comprehensive tobacco control program
